SCHEMBL10238317

SCHEMBL10238317

C1=C\C/C=C\N=C/C\C=C/1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL179255 0.87
SCHEMBL2561084 0.85
Hydrogen Sulfide SCHEMBL28325947 0.84
SCHEMBL28121962 0.84
SCHEMBL4563756 0.84
SCHEMBL9905529 0.84
SCHEMBL1423736 0.84
SCHEMBL27827940 0.82
Benzene SCHEMBL11786892 0.81
SCHEMBL1759431 0.73

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9780310-B2 Heterocyclic compound for organic electroluminescent device and its application TOSOH CORPORATION (JP) 2017-10-03 US disclosed
US-9583715-B2 Anthracene-based compounds and organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2017-02-28 US disclosed
WO-2014123900-A1 ANTI-CANCER AND ANTI-HIV COMPOUNDS SIRENAS MARINE DISCOVERY (US) 2014-08-14 WO disclosed
EP-2328890-B1 6 SUBSTITUTED 2-HETEROCYCLYLAMINO PYRAZINE COMPOUNDS AS CHK-1 INHIBITORS PFIZER (US) 2012-01-25 EP disclosed